lymphoma
Adaptive Biotechnologies Wins Expanded Medicare Coverage of ClonoSeq in Mantle Cell Lymphoma
The expanded coverage adds to the existing Medicare payment structure for ClonoSeq, which provides coverage for a bundle of tests to assess patient therapy response.
Tempus, IFLI Partner to Accelerate Development of Follicular Lymphoma Therapies
The collaboration will involve making a real-world multimodal dataset available in Tempus' Lens platform that researchers can use to accelerate treatment development.
NeoGenomics, Adaptive Biotech Partner to Offer Combined Blood Cancer Testing
Doctors ordering NeoGenomics Compass test packages will have the option of including Adaptive's ClonoSeq minimal residual disease assay.
BeiGene, CLL Society Partner to Promote Biomarker Testing in CLL, SLL
The partnership will support a campaign intended to increase the use of genomic testing to guide personalized therapy and improve outcomes.
City of Hope, Institute for Follicular Lymphoma Innovation Partner on $2M Research Program
The three-year effort will use DNA profiling, proteomics, and machine learning techniques to explore potential triggers of spontaneous remission.